Search
My Stocks
SGX
Google
Yahoo
News
TradingView
IX BIOPHARMA LTD. W260718 (HQXW)
SGD 0.052
-5.77% 0.00
Portfolio
Watchlist
Divs
Anns
Trans
Notes
Articles
All
Financial
Buy Back
Insider Trading
2025-11-17
General Announcement::Minutes of Annual General Meeting Held on 24 October 2025
2025-11-09
General Announcement::Entry Into Term Sheet for Proposed JV to Establish Manufacturing and Commercialisation in USA
2025-10-31
Placements::Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Proposed Placement Completion
2025-10-28
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt
2025-10-28
General Announcement::Request for Lifting of Trading Halt - Sponsor's Statement
2025-10-27
Request for Trading Halt::Request for Trading Halt
2025-10-07
Annual Reports and Related Documents::
2025-09-30
Financial Statements and Related Announcement::Auditor's Comments of Accounts
2025-05-23
General Announcement::Notice of End of Conversion Period and Maturity Date of Convertible Bonds
2025-03-26
General Announcement::Minutes of Extraordinary General Meeting Held on 10 March 2025
2025-02-20
General Announcement::Proposed Appointment of Auditors and Proposed Issuance of Shares to Directors
2025-02-07
General Announcement::Press Release - iX Biopharma Delivers 39% Revenue Growth in 1H25, Reduces Operating Cash Burn by 33%
2024-11-19
General Announcement::Press Release - iXB 401 Achieves 20x Higher Bioavailability Than Rybelsus in Preclinical Study
2024-11-15
General Announcement::Minutes of Extraordinary General Meeting Held on 17 October 2024
2024-10-17
General Announcement::Formation of the Audit and Risk Committee and Reconstitution of the Board Committees
2024-10-14
General Announcement::Press Release - iX Biopharma Appoints Dr. Brian Kennedy as New Scientific Advisor
2024-09-16
General Announcement::Press Release - Business and Drug Development Updates - Wafermine and iXB 401
2024-09-01
General Announcement::Press Release - New Study Demonstrates that SL-NAD+ Delivers NAD+ into Cells
2024-08-23
Financial Statements and Related Announcement::Full Yearly Results
2024-07-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang
2024-07-24
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest by Substantial Shareholder - Anson Properties Pte. Ltd.
2024-07-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung
2024-07-22
REPL::General Announcement::Issue and Listing of the Rights Shares and the Warrants
2024-07-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang
© 2025 Dividends.sg /
More Countries